For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Digital privacy icebergs remain hazards in the water as the Privacy Act 2020 prepares to set sail
+Print Archive
Business
Digital privacy icebergs remain hazards in the water as the Privacy Act 2020 prepares to set sail
Wednesday 29 July 2020, 01:30 AM

The Privacy Act 2020 sets sail soon. Alex Poor says the new act has missed the opportunity to future-proof laws
OPINION
Alex Poor dissects the update of New Zealand’s privacy laws
The Privacy Act 2020 falls short in several key aspects of digital privacy and data sovereignty.
The act repeals and replaces the Privacy Act 199
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.